1st Quarter - Report

RAI SERVICES COMPANY for RAI SERVICES COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$790,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 22, 2019 $790,000 Replaced
1st Quarter - Amendment Jul 22, 2019 $840,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues surrounding prevention of illicit tobacco, tariffs, duty and customs.

Foreign entity interest: As the ultimate parent entity of RAI Services Company, British American Tobacco p.l.c., disclosed on the LD-1, has an interest in the issues above.

LobbyistCovered position, as disclosed
LAKEITHA ANDERSON —
RICHARD L HASELWOOD —
JEFFREY HOGG —
CARA DALMOLIN MOON —
FLORA OKEREKE —

Contacted: SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; White House Office; Office of Management & Budget (OMB)

Tobacco TOB

H.R. 293, Youth Vaping Prevention Act of 2019 - All provisions in the bill. H.R. 1498/S. 655, SAFE Kids Act - All provisions in the bill. H.R. 1642, Combating the Illicit Trade in Tobacco Products Act - All provisions in the bill. S. 616, E-Cigarette Youth Protection Act - All provisions in the bill. Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act. FDAs proposed rule concerning NNN Levels in Smokeless Tobacco Products ANPRMS for Docket Nos. FDA-2017-N-6189, FDA-2017-N-6565, and FDA-2017-N-6107 Draft Guidance for Certain Marketed Tobacco Products, Docket No. FDA-2018-D-3244-0001

Foreign entity interest: As the ultimate parent entity of RAI Services Company, British American Tobacco p.l.c., disclosed on the LD-1, has an interest in the issues above.

LobbyistCovered position, as disclosed
LAKEITHA ANDERSON —
RICHARD L HASELWOOD —
JEFFREY HOGG —
CARA DALMOLIN MOON —
FLORA OKEREKE —

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; U.S. Trade Representative (USTR); White House Office; Food & Drug Administration (FDA)

Bills named: H.R. 293 (116th), H.R. 1642 (116th), S. 655 (116th), S. 616 (116th), H.R. 1498 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.